A mixed hp FEM for the approximation of fourth‐order singularly perturbed problems on smooth domains

We consider fourth‐order singularly perturbed problems posed on smooth domains and the approximation of their solution by a mixed Finite Element Method on the so‐called Spectral Boundary Layer Mesh. We show that the method converges uniformly, with respect to the singular perturbation parameter, at an exponential rate when the error is measured in the energy norm. Numerical examples illustrate our theoretical findings.     

A fast iterative method to find the matrix geometric mean of two HPD matrices

The purpose of this research is to present a novel scheme based on a quick iterative scheme for calculating the matrix geometric mean of two Hermitian positive definite (HPD) matrices. To do this, an iterative scheme with global convergence is constructed for the sign function using a novel three‐step root‐solver. It is proved that the new scheme is convergent and shown to have global convergence behavior for this target, when square matrices having no pure imaginary eigenvalues. Next, the constructed scheme is used and extended through a well‐known identity for the calculation of the matrix geometric mean of two HPD matrices. Ultimately, several experiments are collected to show its usefulness.     

第二类端点奇异Fredholm积分方程的分数阶退化核方法

本文针对第二类端点奇异Fredholm积分方程构造基于分数阶Taylor展开的退化核方法，设计了两种计算格式，一是在全区间上使用分数阶Taylor展开式近似核函数，二是在包含奇点的小区间上采用分数阶插值，在剩余区间上采用分段二次多项式插值逼近核函数.讨论了两种退化核方法收敛的条件，并给出了混合插值法的收敛阶估计.数值算例表明对于非光滑核函数分数阶退化核方法有着良好的计算效果，且混合二次插值法比全区间上的分数阶退化核方法有着更广泛的适用范围.     

Maximizing the mean subtree order

This article focuses on properties and structures of trees with maximum mean subtree order in a given family; such trees are called optimal in the family. Our main goal is to describe the structure of optimal trees in and , the families of all trees and caterpillars, respectively, of order . We begin by establishing a powerful tool called the Gluing Lemma, which is used to prove several of our main results. In particular, we show that if is an optimal tree in or for , then every leaf of is adjacent to a vertex of degree at least . We also use the Gluing Lemma to answer an open question of Jamison and to provide a conceptually simple proof of Jamison's result that the path has minimum mean subtree order among all trees of order . We prove that if is optimal in , then the number of leaves in is and that if is optimal in , then the number of leaves in is . Along the way, we describe the asymptotic structure of optimal trees in several narrower families of trees.     

一类正交空间填充设计的构造

空间填充设计在计算机试验中应用十分广泛,当拟合回归模型时,正交的空间填充设计保证了因子效应估计的独立性.基于广义正交设计,文章给出了构造二阶正交拉丁超立方体设计和列正交设计的方法,新构造的设计不仅满足任意两列之间相互正交,还能保证每一列与任一列元素平方组成的列以及任两列元素相乘组成的列都正交.当某些正交的空间填充设计不存在时,具有较小相关系数的近似正交设计可作为替代设计使用.设计构造的灵活性为计算机试验在实践中的广泛应用提供了必要的支持.     

Hydrogen‐Bonded Films for Zero‐Order Release of Leuprolide

Leuprolide has been widely used in androgen deprivation therapy for the treatment of advanced prostate cancer, but its use is still limited due to its short half‐life. Herein, hydrogen‐bonded layer‐by‐layer films are fabricated from PEGylated leuprolide (PEG‐LEU) and tannic acid (TA). Because of its dynamic nature, the film disintegrates gradually in water and releases PEG‐LEU and TA. The in vitro release profile indicated perfect zero‐order kinetics, which is explained by the unique release mechanism. When implanted subcutaneously in male rats, the films maintain a constant serum drug level. For a 60‐bilayer film, the serum drug level is maintained constant for ≈24 days. No initial burst release is observed, suggesting that the in vivo release also follows zero‐order kinetics. Initially, an increase in the level of serum testosterone is induced by the released drug, followed by testosterone suppression to a constant level below the castrate level, which could be maintained as long as a constant serum drug level is maintained. Since the new drug carriers avoid an initial burst release of the drug and maintain a constant serum drug level and hence a constant serum testosterone level below the castrate level, these carriers are highly promising for androgen deprivation therapy.